DEPMPO
CDEPMPO is a potent anticancer proagent. High concentrations of DEPMPO spin-trap the ·OH radical together with aryl radicals arising from one-electron reduced BTO (benzotriazine 1,4-di-N-oxide) compounds[1].
Product Specifications
CAS Number
[157230-67-6]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Biochemical Assay Reagents
Type
Reference compound
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/depmpo.html
Purity
99.84
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
[O-][N+]1=CCCC1(C)P(OCC)(OCC)=O
Molecular Formula
C9H18NO4P
Molecular Weight
235.22
Precautions
H302, H315, H319, H335
References & Citations
[1]Qi W, et al. Spin Trapping Hydroxyl and Aryl Radicals of One-Electron Reduced Anticancer Benzotriazine 1,4-Dioxides. Molecules. 2022 Jan 26;27 (3) :812.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6282793-01 0.1 mL
CD14, NT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (MaxLight 750)
Ask
View Details 
MBS6282793-02 5x 0.1 mL
CD14, NT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (MaxLight 750)
Ask
View Details